AI Could Eventually Crack Cancer and Drug Discovery, Says Arm CEO — But This Is What’s Holding It Back
Arm Holdings PLC (NASDAQ: ARM) CEO Rene Haas said AI could help find a cure for cancer within our lifetime, but warned that chip shortages are limiting the expansion of AI infrastructure.
The CEO thinks AI might help doctors cure cancer someday, but right now there aren't enough computer chips being made to power all the AI we need. When you see this company's stock, remember that AI's big potential depends on having enough chips available.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.